method)&#32

3 trials

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences, Shandong Cancer Hospital, The First Affiliated Hospital of Guangxi Medical University

Conditions

Abnormal fibrinogenNon-small-cell Lung Cancerprimary liver cancer

Early Phase 1

The clinical trial on EGFR T790M mutation detection kit (digital PCR method)

Active, not recruitingChiCTR2100043147

Cancer Hospital, Chinese Academy of Medical SciencesNon-small-cell Lung Cancer

Start: 2018-04-01Updated: 2021-05-24

Clinical trial of abnormal prothrombin (PIVKA-II) assay kit (magnetic particle chemiluminescence method)

Active, not recruitingChiCTR2100048500

Shandong Cancer Hospitalprimary liver cancer

Start: 2021-08-01Updated: 2022-03-21

Experimental diagnosis of patients with abnormal fibrinogen

RecruitingChiCTR2100050709

The First Affiliated Hospital of Guangxi Medical UniversityAbnormal fibrinogen

Start: 2021-09-01Updated: 2022-05-02

Related Papers

A large-scale, multicentered trial evaluating the sensitivity and specificity of digital PCR versus ARMS-PCR for detecting ctDNA-based EGFR p.T790M in non-small-cell lung cancer patients

Translational Lung Cancer Research2021-10-0125 citations